These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8530011)

  • 1. A nonsense mutation in the cytochrome P450 CYP2D6 gene identified in a Caucasian with an enzyme deficiency.
    Broly F; Marez D; Lo Guidice JM; Sabbagh N; Legrand M; Boone P; Meyer UA
    Hum Genet; 1995 Nov; 96(5):601-3. PubMed ID: 8530011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An efficient strategy for detection of known and new mutations of the CYP2D6 gene using single strand conformation polymorphism analysis.
    Broly F; Marez D; Sabbagh N; Legrand M; Millecamps S; Lo Guidice JM; Boone P; Meyer UA
    Pharmacogenetics; 1995 Dec; 5(6):373-84. PubMed ID: 8747409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A BamHI polymorphism in the human cytochrome P450 gene, CYP2D6.
    Morimoto Y; Murayama N; Kuwano A; Yoshimura O; Kondo I
    Clin Genet; 1995 Feb; 47(2):103-4. PubMed ID: 7606840
    [No Abstract]   [Full Text] [Related]  

  • 4. An additional allelic variant of the CYP2D6 gene causing impaired metabolism of sparteine.
    Marez D; Legrand M; Sabbagh N; Lo-Guidice JM; Boone P; Broly F
    Hum Genet; 1996 May; 97(5):668-70. PubMed ID: 8655150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphism of debrisoquine oxidation: restriction fragment analysis and allele-specific amplification of mutant alleles of CYP2D6.
    Heim MH; Meyer UA
    Methods Enzymol; 1991; 206():173-83. PubMed ID: 1686063
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of debrisoquine hydroxylation phenotypes.
    Wolf CR; Moss JE; Miles JS; Gough AC; Spurr NK
    Lancet; 1990 Dec; 336(8728):1452-3. PubMed ID: 1978915
    [No Abstract]   [Full Text] [Related]  

  • 7. An association study of debrisoquine hydroxylase (CYP2D6) polymorphisms in schizophrenia.
    Dawson E; Powell JF; Nöthen MM; Crocq MA; Lanczik M; Körner J; Rietschel M; van Os J; Wright P; Gill M
    Psychiatr Genet; 1994; 4(4):215-8. PubMed ID: 7712118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.
    Johansson I; Lundqvist E; Bertilsson L; Dahl ML; Sjöqvist F; Ingelman-Sundberg M
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11825-9. PubMed ID: 7903454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymerase chain reaction-single-strand conformation polymorphism based determination of two major genetic defects responsible for a phenotypic polymorphism of cytochrome P450 (CYP) 2C19 in the Japanese population.
    Itoh K; Inoue K; Nakao H; Yanagiwara S; Tada H; Suzuki T
    Anal Biochem; 2000 Aug; 284(1):160-2. PubMed ID: 10933870
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of the primary gene defect at the cytochrome P450 CYP2D locus.
    Gough AC; Miles JS; Spurr NK; Moss JE; Gaedigk A; Eichelbaum M; Wolf CR
    Nature; 1990 Oct; 347(6295):773-6. PubMed ID: 1978251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel CYP2D6 allele with an abolished splice recognition site associated with the poor metabolizer phenotype.
    Marez D; Sabbagh N; Legrand M; Lo-Guidice JM; Boone P; Broly F
    Pharmacogenetics; 1995 Oct; 5(5):305-11. PubMed ID: 8563771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Debrisoquine oxidation polymorphism: phenotypic consequences of a 3-base-pair deletion in exon 5 of the CYP2D6 gene.
    Broly F; Meyer UA
    Pharmacogenetics; 1993 Jun; 3(3):123-30. PubMed ID: 8101460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A polymorphic CfoI site in exon 6 of the human cytochrome P450 CYP2D6 gene detected by the polymerase chain reaction.
    Armstrong M; Idle JR; Daly AK
    Hum Genet; 1993 Jul; 91(6):616-7. PubMed ID: 8340116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black Americans.
    Evans WE; Relling MV; Rahman A; McLeod HL; Scott EP; Lin JS
    J Clin Invest; 1993 May; 91(5):2150-4. PubMed ID: 8098046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population.
    Aynacioglu AS; Sachse C; Bozkurt A; Kortunay S; Nacak M; Schröder T; Kayaalp SO; Roots I; Brockmöller J
    Clin Pharmacol Ther; 1999 Aug; 66(2):185-92. PubMed ID: 10460072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology.
    Steen VM; Andreassen OA; Daly AK; Tefre T; Børresen AL; Idle JR; Gulbrandsen AK
    Pharmacogenetics; 1995 Aug; 5(4):215-23. PubMed ID: 8528268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutations of CYP3A4 in Chinese.
    Hsieh KP; Lin YY; Cheng CL; Lai ML; Lin MS; Siest JP; Huang JD
    Drug Metab Dispos; 2001 Mar; 29(3):268-73. PubMed ID: 11181494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R296C and other CYP2D6 mutations in Chinese.
    Wang SL; Lai MD; Lai ML; Huang JD
    Pharmacogenetics; 1995 Dec; 5(6):385-8. PubMed ID: 8747410
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.
    Johansson I; Oscarson M; Yue QY; Bertilsson L; Sjöqvist F; Ingelman-Sundberg M
    Mol Pharmacol; 1994 Sep; 46(3):452-9. PubMed ID: 7935325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and sequencing of a new non-functional CYP2D6 allele: deletion of T1795 in exon 3 generates a premature stop codon.
    Evert B; Griese EU; Eichelbaum M
    Pharmacogenetics; 1994 Oct; 4(5):271-4. PubMed ID: 7894499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.